Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts
PROTEOMICS · 2024
DOI: 10.1002/pmic.202300267 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, 2024. Verfasst von Yanfang Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, Hunter Medical Research Institute, University of Newcastle; an…. Hauptthemen laut MEDLINE: Proteome, Proteomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council Future Fellowship, Cancer Council NSW, Cancer Institute NSW.
Abstract (Originalsprache)
Fibroblasts are the most common cell type in stroma and function in the support and repair of most tissues. Mouse embryonic fibroblasts (MEFs) are amenable to isolation and rapid growth in culture. MEFs are therefore widely used as a standard model for functional characterisation of gene knockouts, and can also be used in co‐cultures, commonly to support embryonic stem cell cultures. To facilitate their use as a research tool, we have performed a comprehensive proteomic and phosphoproteomic characterisation of wild‐type primary MEFs from C57BL/6 mice. EIF2/4 and MTOR signalling pathways were abundant in both the proteome and phosphoproteome, along with extracellular matrix (ECM) and cytoskeleton associated pathways. Consistent with this, kinase enrichment analysis identified activation of P38A, P90RSK, P70S6K, and MTOR. Cell surface markers and matrisome proteins were also annotated. Data are available via ProteomeXchange with identifier PXD043244. This provides a comprehensive catalogue of the wild‐type MEF proteome and phosphoproteome which can be utilised by the field to guide future work.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, Hunter Medical Research Institute, University of Newcastle; and Precision Medicine Program, Callaghan, New South Wales, Australia.
- School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, Hunter Medical Research Institute, University of Newcastle; and Cancer Detection and Therapies Program, Callaghan, New South Wales,…
- The Priority Research Centre for Reproductive Science, Hunter Medical Research Institute, The University of Newcastle; and the Infertility and Reproduction Research Program, Callaghan, New South Wales, Australia.
ORCID-Profile: David A Skerrett-Byrne, Heather C Murray
Förderung
- Australian Research Council Future Fellowship
- Cancer Council NSW
- Cancer Institute NSW
- Australian Research Council
- NHMRC
- National Health and Medical Research Council
Zitieren
APA
Chen, Y., Roselli, S., Panicker, N., Brzozowski, J. S., Skerrett-Byrne, D. A., Murray, H. C., & Verrills, N. M. (2024). Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts. PROTEOMICS. https://doi.org/10.1002/pmic.202300267
Vancouver
Chen Y, Roselli S, Panicker N, Brzozowski JS, Skerrett-Byrne DA, Murray HC, et al. Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts. PROTEOMICS. 2024. doi:10.1002/pmic.202300267
BibTeX
@article{Chen2024,
author = {Chen, Yanfang and Roselli, Severine and Panicker, Nikita and Brzozowski, Joshua S and Skerrett-Byrne, David A and Murray, Heather C and Verrills, Nicole M},
title = {Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts},
journal = {PROTEOMICS},
year = {2024},
doi = {10.1002/pmic.202300267}
}
EUVIMED